ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for default Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

RVLP RVL Pharmaceuticals PLC

0,0282
0,00 (0,00%)
Zuletzt aktualisiert: 02:00:00
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
RVL Pharmaceuticals PLC RVLP NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
0,00 0,00% 0,0282 02:00:00
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,0282
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
17.1.202422:05EDGAR2Form 8-K - Current report
20.12.202322:15EDGAR2Form 8-K - Current report
27.11.202312:50GLOBERVL Completes Financial Restructuring
16.11.202315:11EDGAR2Form DEF 14A - Other definitive proxy statements
01.11.202321:27EDGAR2Form SC 13D/A - General statement of acquisition of..
23.10.202322:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23.10.202319:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.10.202323:00EDGAR2Form 8-K - Current report
20.10.202321:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
20.10.202319:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18.10.202322:00EDGAR2Form 144 - Report of proposed sale of securities
13.10.202323:28EDGAR2Form SC 13D/A - General statement of acquisition of..
13.10.202322:15EDGAR2Form 8-K - Current report
12.10.202312:50GLOBERVL Pharmaceuticals plc Announces Prepackaged Reorganization..
29.9.202322:05EDGAR2Form 8-K - Current report
22.9.202322:05EDGAR2Form 8-K - Current report
05.9.202322:18EDGAR2Form DEF 14A - Other definitive proxy statements
05.9.202322:06EDGAR2Form 8-K - Current report
05.9.202313:45EDGAR2Form SC 13D - General statement of acquisition of beneficial..
31.8.202320:23EDGAR2Form D - Notice of Exempt Offering of Securities
25.8.202323:21EDGAR2Form PRE 14A - Other preliminary proxy statements
25.8.202322:17EDGAR2Form 8-K - Current report
23.8.202323:30EDGAR2Form S-3 - Registration statement under Securities Act of..
23.8.202322:05GLOBERVL Pharmaceuticals plc to Present at the H.C. Wainwright..
18.8.202322:06EDGAR2Form 8-K - Current report
17.8.202323:06EDGAR2Form SC 13D/A - General statement of acquisition of..
17.8.202323:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17.8.202322:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
16.8.202314:00GLOBERVL Pharmaceuticals plc Announces $5 Million Registered..
14.8.202323:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14.8.202315:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14.8.202313:51EDGAR2Form 8-K - Current report
14.8.202312:50GLOBERVL Pharmaceuticals plc Reports Second Quarter 2023..
02.8.202323:00EDGAR2Form 8-K - Current report
02.8.202314:30GLOBERVL Pharmaceuticals plc to Discuss Second Quarter 2023..
12.7.202303:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
12.7.202303:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05.7.202312:50GLOBERVL Pharmaceuticals plc Provides Business Update

Kürzlich von Ihnen besucht

Delayed Upgrade Clock